Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎
Titel:
Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎
Auteur:
Palandri, Francesca Palumbo, Giuseppe A. Iurlo, Alessandra Polverelli, Nicola Benevolo, Giulia Breccia, Massimo Abruzzese, Elisabetta Tiribelli, Mario Bonifacio, Massimiliano Tieghi, Alessia Isidori, Alessandro Martino, Bruno Sgherza, Nicola D'Adda, Mariella Bergamaschi, Micaela Crugnola, Monica Cavazzini, Francesco Bosi, Costanza Binotto, Gianni Auteri, Giuseppe Latagliata, Roberto Ibatici, Adalberto Scaffidi, Luigi Penna, Domenico Cattaneo, Daniele Soci, Francesco Trawinska, Malgorzata Russo, Domenico Cuneo, Antonio Semenzato, Giampietro Di Raimondo, Francesco Aversa, Franco Lemoli, Roberto M. Heidel, Florian Reggiani, Maria L.B. Bartoletti, Daniela Cavo, Michele Catani, Lucia Vianelli, Nicola